Fierce Pharma
AUGUST 28, 2024
The rightsizing at BioMarin continues to take its toll as CEO Alexander Hardy devises a new corporate strategy for the rare disease biotech. | The rightsizing at BioMarin continues to take its toll as CEO Alexander Hardy devises a new corporate strategy for the rare disease biotech.
PharmaVoice
AUGUST 28, 2024
By rejecting the first MDMA therapy earlier this month, the FDA signaled to the psychedelic drug sector that the road to approval isn’t clear cut.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
AUGUST 28, 2024
Novartis has formed a strategic collaboration with drug delivery specialist Lindy Biosciences to develop self-administered versions of the Swiss pharma’s innovative drugs. | Novartis has formed a strategic collaboration with drug delivery specialist Lindy Biosciences to develop self-administered versions of the Swiss pharma’s innovative drugs.
MedCity News
AUGUST 28, 2024
Over the past decade, Abbott and Dexcom — the two largest makers of continuous glucose monitors — have been teaming up with medical device companies that sell automated insulin delivery systems. Industry experts think these partnerships are smart moves to stay relevant in the rapidly-developing diabetes care space. The post The Surprising Rivalries-Turned-Friendships That Are Shaping Diabetes Technology appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
AUGUST 28, 2024
Delaware's Supreme Court has upheld a GSK appeal, deciding to review the state’s Superior Court decision to allow expert testimony in Zantac lawsuits.
European Pharmaceutical Review
AUGUST 28, 2024
Novartis Pharma AG and biotech Lindy Biosciences have agreed to collaborate to advance subcutaneous biologic injectables. As part of a worldwide licensing agreement and collaboration, some of Novartis’ medicines will be developed into the injections via Lindy Biosciences’ proprietary microglassification suspension technology. This platform enables high concentrations of biologics to be delivered in a single dose, improving the convenience of administration and patient and treatment compliance, a
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
AUGUST 28, 2024
To address the complicated healthcare landscape in the U.S., Pfizer launched a new direct-to-consumer virtual service called PfizerForAll. It follows Eli Lilly, which launched a similar product in January. The post Why Pfizer Is Dipping Into DTC Telehealth With PfizerForAll appeared first on MedCity News.
Fierce Pharma
AUGUST 28, 2024
As Stada Arzneimittel’s private equity owners continue to weigh their options around a potential sale or public offering, the German drugmaker gave a good indication Wednesday of exactly what it ca | As Stada Arzneimittel’s private equity owners continue to weigh their options around a potential sale or public offering, the German drugmaker gave a good indication Wednesday of exactly what it can bring to the table.
MedCity News
AUGUST 28, 2024
Sluggish margins and high costs have created a challenging environment for provider organizations. With the number of denied claims increasing significantly over the past few years, so has the time and resources needed to manage those denials. The post Building an Effective Denial Prevention Team to Mitigate Revenue Loss appeared first on MedCity News.
Pharmaceutical Commerce
AUGUST 28, 2024
Session uncovers distributors’ experiences with the Waiver, Exception, or Exemption request process, and how these affect the overall supply chain.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
AUGUST 28, 2024
The £400m pledged by industry as part of the new VPAG voluntary scheme of pharma rebates will be used mainly to support the UK clinical research sector
MedCity News
AUGUST 28, 2024
States can improve efficiency, reduce administrative costs, and, most importantly, enhance the quality of health care for its members by acting in these areas. The post Improve the Medicaid Provider Experience to Enhance Health Care appeared first on MedCity News.
pharmaphorum
AUGUST 28, 2024
A virtual voice assistant used to contact patients after heart procedures can make early discharge possible and spot complications
Pharmaceutical Commerce
AUGUST 28, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Jeb Hunter, Senior Regulatory Consultant, EAS Consulting Group, discusses the on “What to Expect When They’re Inspecting: FDA Inspections on DSCSA Compliance" breakout session at the 2024 HDA Traceability Seminar.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Clarivate
AUGUST 28, 2024
A glimpse at patient flows on and off of JANUVIA® in France shows just how rapidly generic uptake can overtake a branded drug after loss of exclusivity. Fig. 1: Patient flows for Januvia versus generic sitagliptine, post-LOE, in France Source: Clarivate Patient Data Intelligence Merck/MSD’s DPP-IV inhibitor JANUVIA (sitagliptin) lost exclusivity for type 2 diabetes in Europe at the end of 2021.
pharmaphorum
AUGUST 28, 2024
Novartis builds case for fast-growing cholesterol drug Leqvio, as V-MONO trial shows benefit as a monotherapy in patients at lower risk of heart disease
Pharmaceutical Commerce
AUGUST 28, 2024
The latest news for pharma industry insiders.
pharmaphorum
AUGUST 28, 2024
ADCs are designed to deliver chemotherapy directly to tumours. However, more than 95% of the dose often ends up in healthy tissues, decreasing efficacy and increasing toxicity. Self-navigating ADCs, however, might offer a solution. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Brian Fiske, chief scientific officer of Mythic Therapeutics, about minimising side effects for patients and the notion of patient-centred science.
PharmaTimes
AUGUST 28, 2024
The partnership will improve care for patients with pancreatic cancer
pharmaphorum
AUGUST 28, 2024
Learn why storytelling is crucial in scientific publications. The webinar will showcase examples of storytelling for clinical data, discuss trends, and explore opportunities for data storytelling to enhance health equity through plain-language content and publication extenders.
Evolve Your Success
AUGUST 28, 2024
Join us for an enlightening conversation with the distinguished Dr. Alejandro Badia, a world-renowned hand surgeon and healthcare advocate. Dr. Badia’s journey from his immigrant roots to becoming a leading medical practitioner in Miami is truly inspiring. Learn how a childhood experience with his grandmother’s rheumatoid arthritis ignited his passion for hand surgery, leading to his extensive training at N.Y.U. and a transformative fellowship in Pittsburgh.
pharmaphorum
AUGUST 28, 2024
Pharma marketing is going through an evolution, scaling mass messaging with personalised outreach powered by complex systems. In this deep dive into innovation in content transformation, pharmaceutical companies can learn how to move from pilot projects to scalable models. We'll share innovative approaches to personalise customer engagement, accelerate content generation, and drive the greatest impact for your brand.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaTimes
AUGUST 28, 2024
However the company will not continue developing the candidate
pharmaphorum
AUGUST 28, 2024
MSD starts phase 3 trial of oral LSD1 inhibitor bomedemstat as a first-line option for blood cancer essential thrombocythaemia
PharmExec
AUGUST 28, 2024
Topline results from the Phase III V-MONO study of Leqvio found that twice-yearly Leqvio achieved clinically LDL-C lowering compared to both placebo and ezetimibe.
PharmaTech
AUGUST 28, 2024
The completed acquisition of Morphic expands Lilly's immunology pipeline with Morphic's oral integrin therapies for treating inflammatory bowel disease.
PharmExec
AUGUST 28, 2024
A new National Institutes of Health grant will advance research into the role of the serotonin 5-HT2A receptor in mitigating methamphetamine use.
Pharmaceutical Technology
AUGUST 28, 2024
Pfizer has launched a new digital platform, PfizerForAll, aimed at simplifying the process of accessing healthcare for millions of Americans.
PharmExec
AUGUST 28, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
AUGUST 28, 2024
With new oesophageal cancer cases annually projected to increase by 80% before 2050, find out more about current and developing treatments.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
299 
Let's personalize your content